Pousette Andreas

Andreas has four years of experience as a health economist at Swedish Dental and Pharmaceutical Benefits Agency (TLV). At TLV, Andreas was involved in numerous health economic assessments (HTA) of reimbursement submissions including evaluations to The New Therapies (NT) Council. Andreas has a broad HTA experience in a wide range of disease areas such as cardiovascular disease, immunology to metabolic and rare genetic disorders.

Education: Degree of Master of Science in Public Health with a Specialisation in Health Economics, Umeå University